Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SIGVARIS Management is the Swiss management company and main office of SIGVARIS GROUP, a long-established family-owned healthcare business focused on medical compression therapy. The group develops, manufactures, and commercializes compression garments and related solutions used for venous and lymphatic conditions, including lymphedema, lipedema, edema, and venous leg ulcers, as well as products for prevention and daily wear. SIGVARIS is not a drug-development biotech or pharma company; it operates primarily as a medical device and compression-therapy company with commercial products on the market globally. The management entity provides centralized services across the group, including finance, controlling, IT, corporate relations, production, product research, branding, and patents. The broader SIGVARIS GROUP is headquartered in St. Gallen, Switzerland and maintains operating companies across Europe, North America, South America, and Australia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SIGVARIS Management.